|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/09 | |
| C07K 7/06 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2553096 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11762265.4 |
| Europos patento paraiškos padavimo data | 2011-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2011/001909 |
| Data | 2011-03-30 |
| (87) | Numeris | WO 2011/122022 |
| Data | 2011-10-06 |
| (30) | Numeris | Data | Šalis |
| 320577 P | 2010-04-02 | US |
| (72) |
NAKAMURA, Yusuke, JP
TSUNODA, Takuya, JP
OHSAWA, Ryuji, JP
YOSHIMURA, Sachiko, JP
WATANABE, Tomohisa, JP
|
| (73) |
Oncotherapy Science, Inc.,
2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012,
JP
|
| (54) | ECT2 PEPTIDES AND VACCINES INCLUDING THE SAME |
| ECT2 PEPTIDES AND VACCINES INCLUDING THE SAME |